Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocation details updated: New York and Washington sites added; related location sections adjusted and the HHS disclosure link removed (revision v3.3.3).SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the government funding operating status notice from the page, including references to cc.nih.gov and opm.gov. This notice previously informed users about potential delays in updates; its removal does not affect the study details presented.SummaryDifference0.4%

- Check62 days agoChange DetectedComparison shows no changes to core study information (title, conditions, interventions, eligibility criteria, and outcomes). Any differences are limited to layout and visual presentation.SummaryDifference0.4%

- Check91 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check98 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.